A patent reflects a bargain between the inventor and the public. The inventor gains a time-limited monopoly over the making and use of a product. …
The recent FDA approval of siRNA therapeutics has re-energised the RNA interference (RNAi) field. The discovery of RNAi mediated silencing in mammalian cells and parallel …
SARS-CoV-2, or the pathogen which causes COVID-19, is a virus containing a positive-sense RNA as its genetic constituent.Morphologically, it contains spike-like projections on its surface …
The pharmaceutical industry has long been squeezed by tight regulation, cost controls on medicines, and the necessarily extensive drug discovery and research process. There is …
Unlike genomic and transcriptomic research, the measurement technologies for proteomics are still evolving, and the complete analysis of a proteome has not yet been achieved. …
For the first time in history, most people can expect to live into their 60s and beyond. According to the World Health Organisation, one in …
Different inhaled product development programmes can use different platform delivery technologies at various stages of development. Sandy Munro at Vectura shows why careful thought must …
The use of compounds (from biologic or chemical origin) as therapeutics is as old as mankind. Traditionally, the administering of such therapeutic products to the …
Inspection systems help print shops perform a 100% print inspection and save time at the implementation of new jobs, due to automated job setups and …
The race is on amongst the international scientific research community to develop a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19. …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative